Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 27 04:00PM ET
0.7768
Dollar change
-0.0060
Percentage change
-0.77
%
Index- P/E- EPS (ttm)-0.13 Insider Own0.44% Shs Outstand408.55M Perf Week-5.13%
Market Cap317.36M Forward P/E- EPS next Y-0.16 Insider Trans20.03% Shs Float406.74M Perf Month12.04%
Income-52.56M PEG- EPS next Q-0.04 Inst Own22.67% Short Float / Ratio3.91% / 10.13 Perf Quarter-25.31%
Sales323.77M P/S0.98 EPS this Y35.75% Inst Trans-7.35% Short Interest15.89M Perf Half Y-34.72%
Book/sh1.35 P/B0.57 EPS next Y2.40% ROA-6.02% Target Price1.31 Perf Year-33.61%
Cash/sh0.79 P/C0.99 EPS next 5Y38.90% ROE-9.21% 52W Range0.65 - 2.23 Perf YTD-35.80%
Dividend- P/FCF- EPS past 5Y-0.85% ROI-9.35% 52W High-65.17% Beta2.11
Dividend %- Quick Ratio1.74 Sales past 5Y22.90% Gross Margin56.18% 52W Low19.32% ATR0.05
Employees365 Current Ratio2.69 Sales Q/Q-26.30% Oper. Margin-19.13% RSI (14)51.27 Volatility4.56% 6.94%
OptionableYes Debt/Eq0.02 EPS Q/Q-273.02% Profit Margin-16.23% Rel Volume0.77 Prev Close0.78
ShortableYes LT Debt/Eq0.02 EarningsNov 01 BMO Payout- Avg Volume1.57M Price0.78
Recom3.33 SMA204.77% SMA50-2.80% SMA200-35.31% Volume1,199,744 Change-0.77%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Oct-25-23Downgrade Jefferies Buy → Hold $3 → $1
Jan-06-23Upgrade Jefferies Hold → Buy $1.30 → $3
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
Nov-12-23 09:00AM
Nov-02-23 10:58AM
Nov-01-23 12:30PM
12:03PM
09:30AM
09:25AM Loading…
09:25AM
07:30AM
07:00AM
Oct-31-23 12:00PM
Oct-26-23 08:00AM
Oct-23-23 10:08AM
Oct-19-23 08:00AM
Sep-12-23 08:00AM
Aug-24-23 09:29AM
Aug-19-23 11:22AM
04:05PM Loading…
Aug-09-23 04:05PM
Aug-08-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:22AM
Aug-02-23 07:33AM
07:11AM
Jul-31-23 08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jul-25-23 04:05PM
Jul-20-23 08:00AM
Jul-19-23 12:58PM
11:19AM
Jul-18-23 04:16PM
04:15PM
11:43AM Loading…
Jul-05-23 11:43AM
Jun-21-23 09:00AM
Jun-08-23 11:07AM
Jun-01-23 04:30PM
06:00AM
May-23-23 09:50AM
May-12-23 11:00AM
May-03-23 02:00PM
01:47PM
07:41AM
07:00AM
May-02-23 01:32PM
Apr-19-23 08:00AM
Apr-17-23 07:00AM
Apr-13-23 10:18AM
Apr-12-23 09:18AM
Apr-04-23 03:53PM
08:00AM
Mar-16-23 08:00AM
Mar-06-23 04:05PM
09:37AM
08:00AM
Mar-05-23 10:21AM
Mar-03-23 11:09AM
Mar-02-23 01:23PM
11:44AM
05:55AM
Mar-01-23 11:02AM
11:00AM
07:00AM
Feb-28-23 11:11AM
10:39AM
10:38AM
08:00AM
Feb-27-23 04:29PM
08:00AM
07:15AM
Feb-24-23 11:52AM
Feb-22-23 04:50PM
08:00AM
Feb-21-23 08:30AM
08:00AM
Feb-20-23 01:00PM
Feb-17-23 09:03AM
07:30AM
Feb-16-23 04:05PM
12:34PM
09:44AM
Feb-15-23 04:29PM
Feb-14-23 05:09PM
09:55AM
Feb-13-23 07:47PM
09:40AM
08:00AM
08:00AM
Feb-09-23 05:27PM
08:00AM
Feb-07-23 04:35PM
Feb-06-23 08:00AM
Feb-03-23 05:16PM
Feb-02-23 04:30PM
Feb-01-23 04:09PM
Jan-31-23 08:24AM
Jan-27-23 06:35PM
08:45AM
08:00AM
Jan-23-23 11:01AM
Jan-20-23 10:04AM
Jan-19-23 09:15PM
12:04PM
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holt PatrickPresident and CEOAug 16Buy1.04300,000312,315300,000Aug 16 07:51 PM